| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns nasal pharmaceutical compositions for treating allergic rhinitis, containing beclometasone in the form of aqueous suspension with a specific profile of particle size distribution. ^ EFFECT: invention provides higher bioavailability, improved effectiveness or long therapeutic effect of the pharmaceutical composition in intranasal introduction. ^ 49 cl, 1 ex, 2 tbl, 4 dwg |
